Cleo Diagnostics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Feb '26 Feb 24, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Market Capitalization	82	50	44	-
Market Cap Growth	59.76%	14.71%	-	-
Enterprise Value	73	43	34	-
Last Close Price	0.60	0.39	0.34	-
PS Ratio	33.37	59.30	207.25	-
PB Ratio	9.30	8.59	4.65	-
P/TBV Ratio	9.67	9.15	4.86	-
EV/Sales Ratio	29.54	50.65	159.30	-
Debt / Equity Ratio	-	-	-	-1.70
Net Debt / Equity Ratio	-1.11	-1.11	-1.00	-1.44
Net Debt / EBITDA Ratio	1.61	1.61	2.62	-0.82
Net Debt / FCF Ratio	2.22	2.22	4.61	-1.88
Asset Turnover	0.10	0.10	0.04	-
Quick Ratio	5.93	5.93	19.40	0.13
Current Ratio	5.94	5.94	19.41	0.29
Return on Equity (ROE)	-52.53%	-52.53%	-88.99%	-
Return on Assets (ROA)	-30.35%	-30.35%	-41.55%	-
Return on Capital Employed (ROCE)	-70.00%	-70.00%	-38.80%	180.20%
Earnings Yield	-4.91%	-7.98%	-8.60%	-
FCF Yield	-3.07%	-5.81%	-4.65%	-
Buyback Yield / Dilution	-9.53%	-9.53%	-346.76%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.